The alteration of the lysine acetyltransferase activity and protein–protein interactions of the transcriptional co‐activators CREB‐binding protein (CBP) and p300 is linked to the development of both solid and hematological cancers. Here, CREBBP is linked to hematopoietic and lymphoid cell neoplasm.